New Challenges for HDL-Modifying Therapies as a Strategy to Lower Cardiovascular Disease Events in Statin-Treated Patients
Crossref DOI link: https://doi.org/10.1007/s10557-015-6576-7
Published Online: 2015-02-24
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosenson, Robert S.
Brewer, H. Bryan Jr.
Text and Data Mining valid from 2015-02-01
Article History
First Online: 24 February 2015